Genetic Screening
  • Home
  • Genetic Screening

Genetic Carrier Screening

Carrier screening is a genetic test that determines if you are at an increased risk of having a child affected with a genetic disease. Experts recommend that all individuals planning a family be offered genetic carrier screening, and for that reason, it is typically performed during one of your first appointments.

We partner with leading genetics laboratory CooperGenomics to offer the CarrierMapSM expanded carrier screen, which uses a small blood or saliva sample to screen your DNA for over 300 conditions such as cystic fibrosis, spinal muscular atrophy (SMA), and sickle-cell disease.

CooperGenomics has a team of board-certified genetic counselors who are available to review your results with you in the context of your personal and family medical history. If you are found to be at increased risk to pass on a genetic disease, there are a number of options available to you. One option, called PGD (preimplantation genetic diagnosis), involves genetically testing IVF embryos and then transferring only embryos that do not have the disease in question.

To learn more about carrier screening, visit www.coopergenomics.com.

Genetic Screening

PGS – Preimplantation Genetic Screening

PGS (or preimplantation genetic screening) is a genetic test performed on embryos, with the goal of improving the chance of IVF success. PGS works by looking at the amount of genetic material within IVF embryos.

Genetic material is housed within structures called chromosomes. Chromosomes are very important for healthy growth and development. Embryos with the incorrect number of chromosomes (also called aneuploid embryos) typically do not result in a successful pregnancy or may lead to the birth of a child with a genetic condition. Embryos with the correct number of chromosomes (also called euploid embryos) have a better chance of leading to a successful pregnancy. PGS identifies embryos with the correct number of chromosomes, so your care team can select the embryo with the best chance of leading to IVF success.

PGS is appropriate for the vast majority of people undergoing IVF. PGS has been shown to have multiple benefits, including:

  • Higher chance of pregnancy
  • Reduced risk of miscarriage
  • More confidence in transferring a single embryo, avoiding health risks associated with twin or triplet pregnancies

We partner with leading genetics laboratory CooperGenomics to offer the most advanced PGS technology. To learn more, visit www.coopergenomics.com.